Compass Pathways Plc (CMPS)
8.61
+0.80
(+10.24%)
USD |
NASDAQ |
Nov 06, 16:00
8.75
+0.14
(+1.63%)
Pre-Market: 20:00
Compass Pathways Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.00 |
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.018M |
| June 30, 2023 | -0.017M |
| Date | Value |
|---|---|
| March 31, 2023 | -0.0293M |
| December 31, 2022 | -0.1117M |
| September 30, 2022 | 0.007M |
| June 30, 2022 | -0.4095M |
| March 31, 2022 | -0.0815M |
| December 31, 2021 | -0.0924M |
| September 30, 2021 | -0.0864M |
| June 30, 2021 | -0.0849M |
| March 31, 2021 | -0.0702M |
| December 31, 2020 | -0.032M |
| September 30, 2020 | -0.015M |
| June 30, 2020 | -0.0407M |
| March 31, 2020 | -0.5403M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Silence Therapeutics Plc | 64.78M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.0453M |
| Mereo BioPharma Group Plc | -0.0004M |
| HemoGenyx Pharmaceuticals Plc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -50.74M |
| Cash from Financing (Quarterly) | 63.01M |
| Free Cash Flow | -176.69M |
| Free Cash Flow Per Share (Quarterly) | -0.3121 |
| Free Cash Flow to Equity (Quarterly) | -50.50M |
| Free Cash Flow to Firm (Quarterly) | -49.60M |
| Free Cash Flow Yield | -15.74% |